Impact of Pharmacist-led Educational Intervention on Pneumococcal Vaccination Rates in Cancer Patients

NACompletedINTERVENTIONAL
Enrollment

228

Participants

Timeline

Start Date

July 19, 2019

Primary Completion Date

December 31, 2020

Study Completion Date

February 15, 2021

Conditions
Pneumonia, BacterialCancerPneumococcal Infections
Interventions
BEHAVIORAL

vaccine education

The educational content was developed based on research and expert perspectives and included general information about immunization, pneumonia, and pneumococcal vaccines, as well as vaccine myths. This information was first conveyed to the patients verbally, and then booklets with the same material were handed to them. The Pneumococcal Conjugate Vaccine 13 (PCV13) vaccination was recommended based on Infectious Disease Society of America (IDSA), Advisory Committee on Immunization Practices (ACIP), and national adult immunization guidelines.

Trial Locations (1)

06100

Hacettepe University Faculty of Medicine Department of Medical Oncology, Ankara

All Listed Sponsors
lead

Hacettepe University

OTHER

NCT05229081 - Impact of Pharmacist-led Educational Intervention on Pneumococcal Vaccination Rates in Cancer Patients | Biotech Hunter | Biotech Hunter